<DOC>
	<DOC>NCT02241434</DOC>
	<brief_summary>The purpose of this study was to study the effect of stem cell therapy in patients with Duchenne Muscular Dystrophy.</brief_summary>
	<brief_title>Stem Cell Therapy in Duchenne Muscular Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy, Duchenne</mesh_term>
	<criteria>age group of 325 years Duchenne muscular dystrophy diagnosed on the basis of clinical presentation presence of respiratory distress presence of acute infections such as Human Immunodeficient Virus/Hepatitis B Virus/Hepatitis C Virus malignancies acute medical conditions such as respiratory infection, fever, hemoglobin less than 8, bleeding tendency, bone marrow disorder, left ventricular ejection fraction &lt; 30% pregnancy or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Duchenne muscular dystrophy</keyword>
	<keyword>Autologous Bone marrow Mononuclear cell therapy</keyword>
	<keyword>Stem Cells</keyword>
</DOC>